MicroRNAs in diffuse large B‑cell lymphoma (Review)
- Authors:
- Huiyun Ni
- Rong Tong
- Linqing Zou
- Guoqi Song
- William C. Cho
-
Affiliations: Department of Hematology, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, P.R. China, Department of Anatomy, Nantong University College of Medicine, Nantong, Jiangsu 226001, P.R. China, Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong 999077, P.R. China - Published online on: December 28, 2015 https://doi.org/10.3892/ol.2015.4064
- Pages: 1271-1280
This article is mentioned in:
Abstract
|
Lossos IS and Morgensztern D: Prognostic biomarkers in diffuse large B-Cell lymphoma. J Clin Oncol. 24:995–1007. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Westin JR and Fayad LE: Beyond R-CHOP and the IPI in large-cell lymphoma: Molecular markers as an opportunity for stratification. Curr Hematol Malig Rep. 4:218–224. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Sandhu SK, Croce CM and Garzon R: Micro-RNA expression and function in lymphomas. Adv Hematol. 2011:1–12. 2011. View Article : Google Scholar | |
|
Wang W and Luo YP: MicroRNAs in breast cancer: Oncogene and tumor suppressors with clinical potential. J Zhejiang Univ Sci B. 16:18–31. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Catuogno S, Esposito CL, Quintavalle C, Cerchia L, Condorelli G and De Franciscis V: Recent advance in biosensors for microRNAs detection incancer. Cancers (Basel). 3:1877–1898. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Di Lisio L, Martinez N, Montes-Moreno S, Piris-Villaespesa M, Sanchez-Beato M and Piris P: The role of miRNAs in the pathogenesis and diagnosis of B-cell lymphomas. Blood. 120:1782–1790. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Yu DC, Li QG, Ding XW and Ding YT: Circulating microRNAs: Potential biomarkers for cancer. Int J Mol Sci. 12:2055–2063. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Bouchie A: First microRNA mimic enters clinic. Nat Biotechnol. 31:5772013. View Article : Google Scholar : PubMed/NCBI | |
|
Lawrie CH: MicroRNAs and lymphomagenesis: A functional review. Br J Haematol. 160:571–581. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Löffler D, Brocke-Heidrich K, Pfeifer G, Stocsits C, Hackermüller J, Kretzschmar AK, Burger R, Gramatzki M, Blumert C, Bauer K, et al: Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood. 110:1330–1333. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A and Lund AH: Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem. 283:1026–1033. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, et al: Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 33:e1792005. View Article : Google Scholar : PubMed/NCBI | |
|
Fang C, Zhu DX, Dong HJ, Zhou ZJ, Wang YH, Liu L, Fan L, Miao KR, Liu P, Xu W and Li JY: Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma. Ann Hematol. 91:553–559. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Roehle A, Hoefig KP, Repsilber D, Thorns C, Ziepert M, Wesche KO, Thiere M, Loeffler M, Klapper W, Pfreundschuh M, et al: MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas. Br J Haematol. 142:732–744. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Lawrie CH, Soneji S, Marafioti T, Cooper CD, Palazzo S, Paterson JC, Cattan H, Enver T, Mager R, Boultwood J, et al: Microrna expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int J Cancer. 121:1156–1161. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Caramuta S, Lee L, Ozata DM, Akçakaya P, Georgii-Hemming P, Xie H, Amini RM, Lawrie CH, Enblad G, Larsson C, et al: Role of microRNAs and microRNA machinery in the pathogenesis of diffuse large B-cell lymphoma. Blood Cancer J. 3:e1522013. View Article : Google Scholar : PubMed/NCBI | |
|
Di Lisio L, Sánchez-Beato M, Gómez-López G, Rodríguez ME, Montes-Moreno S, Mollejo M, Menárguez J, Martínez MA, Alves FJ, Pisano DG, et al: MicroRNA signatures in B-cell lymphomas. Blood Cancer J. 2:e572012. View Article : Google Scholar : PubMed/NCBI | |
|
Li C, Kim SW, Rai D, Bolla AR, Adhvaryu S, Kinney MC, Robetorye RS and Aguiar RC: Copy number abnormalities, MYC activity and the genetic fingerprint of normal B cells mechanistically define the microRNA profile of diffuse large B-cell lymphoma. Blood. 113:6681–6690. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Zhong H, Xu L, Zhong JH, Xiao F, Liu Q, Huang HH and Chen FY: Clinical and prognostic significance of miR-155 and miR-146a expression levels in formalin-fixed/paraffin-embedded tissue of patients with diffuse B-cell lymphoma. Exp Ther Med. 3:763–770. 2012.PubMed/NCBI | |
|
Metzler M, Wilda M, Busch K, Viehmann S and Borkhardt A: High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Genes Chromosomes Cancer. 39:167–169. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Linnstaedt SD, Gottwein E, Skalsky RL, Luftig MA and Cullen BR: Virally induced cellular MicroRNA miR-155 plays a key role in B-Cell immortalization by Epstein-Barr virus. J Virol. 84:11670–11678. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Lu F, Weidmer A, Liu CG, Volinia S, Croce CM and Lieberman PM: Epstein-Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence. J Virol. 82:10436–10443. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Rai D, Kim SW, McKeller MR, Dahia PL and Aguiar RC: Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis. Proc Natl Acad Sci USA. 107:3111–3116. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Yin Q, McBride J, Fewell C, Lacey M, Wang X, Lin Z, Cameron J and Flemington EK: MicroRNA-155 is an Epstein-Barr Virus induced gene that modulates Epstein Barr virus regulated gene expression pathways. J Virol. 82:5295–5306. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Bolisetty MT, Dy G, Tam W and Beemon KL: Reticuloendotheliosis virus strain T induces miR-155, which targets JARID2 and promotes cell survival. J Virol. 83:12009–12017. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Eis PS, Tam W, Sun L, Chadburn A, Li Z, Gomez MF, Lund E and Dahlberg JE: Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci USA. 102:3627–3632. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Rai D, Karanti S, Jung I, Dahia PL and Aguiar RC: Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma. Cancer Genet Cytogenet. 181:8–15. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Martín-Pérez D, Vargiu P, Montes-Moreno S, León EA, Rodríguez-Pinilla SM, Lisio LD, Martínez N, Rodríguez R, Mollejo M, Castellvi J, et al: Epstein-Barr virus microRNAs repress BCL6 expression in diffuse large B-cell lymphoma. Leukemia. 26:180–183. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Huang X, Shen Y, Liu M, Bi C, Jiang C, Iqbal J, McKeithan TW, Chan WC, Ding SJ and Fu K: Quantitative proteomics reveals that miR-155 regulates the PI3K-AKT pathway in diffuse large B-cell lymphoma. Am J Pathol. 181:26–33. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Pan X, Wang ZX and Wang R: MicroRNA-21: A novel therapeutic target in human cancer. Cancer Biol Ther. 10:1224–1232. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Si ML, Zhu S, Wu H, Lu Z, Wu F and Mo YY: MiR-21-mediated tumor growth. Oncogene. 26:2799–2803. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Chan JA, Krichevsky AM and Kosik KS: MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 65:6029–6033. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Cheng AM, Byrom MW, Shelton J and Ford LP: Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 33:1290–1297. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu S, Si ML, Wu H and Mo YY: MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem. 282:14328–14336. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, Banham AH, Pezzella F, Boultwood J, Wainscoat JS, et al: Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol. 141:672–675. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Li CH, Fu R, Wang YH, Song WJ, Ruan EB, Qu W, Wang HQ, Wang GJ, Song J, Wang XM, et al: Expression and clinical significance of miR-21 in diffuse large B cell lymphoma. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 22:339–343. 2014.(In Chinese). PubMed/NCBI | |
|
O'Donnell KA, Wentzel EA, Zeller KI, Dang CV and Mendell JT: c-Myc regulated microRNAs modulate E2F1 expression. Nature. 435:839–843. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ and Hammond SM: A microRNA polycistron as a potential human oncogene. Nature. 435:828–833. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Lawrie CH, Chi J, Taylor S, Tramonti D, Ballabio E, Palazzo S, Saunders NJ, Pezzella F, Boultwood J, Wainscoat JS and Hatton CS: Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma. J Cell Mol Med. 13:1248–1260. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Ventura A, Young AG, Winslow MM, Lintault L, Meissner A, Erkeland SJ, Newman J, Bronson RT, Crowley D, Stone JR, et al: Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell. 132:875–886. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Chen W, Houldsworth J, Olshen AB, Nanjangud G, Chaganti S, Venkatraman ES, Halaas J, Teruya-Feldstein J, Zelenetz AD and Chaganti RS: Array comparative genomic hybridization reveals genomic copy number changes associated with outcome in diffuse large B-cell lymphomas. Blood. 107:2477–2485. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Tam W: Micro-classifying diffuse large B-cell lymphomas. Blood. 113:6506–6507. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S, Yatabe Y, Kawahara K, Sekido Y and Takahashi T: A polycistronic microRNA cluster, miR-17–92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res. 65:9628–9632. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Thapa DR, Li X, Jamieson BD and Martínez-Maza O: Overexpression of microRNAs from the miR-17–92 paralog clusters in AIDS-related non-Hodgkin's lymphomas. PLoS One. 6:e207812011. View Article : Google Scholar : PubMed/NCBI | |
|
Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, Wang J, Rajewsky N, Bender TP and Rajewsky K: MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell. 131:146–159. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Tan LP, Wang M, Robertus JL, Schakel RN, Gibcus JH, Diepstra A, Harms G, Peh SC, Reijmers RM, Pals ST, et al: MiRNA profiling of B-cell subsets: Specific miRNA profile for germinal center B cells with variation between centroblasts and centrocytes. Lab Invest. 89:708–716. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Tober J, McGrath KE and Palis J: Primitive erythropoiesis and megakaryopoiesis in the yolk sac are independent of c-myb. Blood. 111:2636–2639. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Calin GA, Cimmino A, Fabbri M, Ferracin M, Wojcik SE, Shimizu M, Taccioli C, Zanesi N, Garzon R, Aqeilan RI, et al: MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci USA. 105:5166–5171. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Alencar AJ, Malumbres R, Kozloski GA, Advani R, Talreja N, Chinichian S, Briones J, Natkunam Y, Sehn LH, Gascoyne RD, et al: MicroRNAs are independent predictors of outcome in diffuse large B-cell lymphoma patients treated with R-CHOP. Clin Cancer Res. 17:4125–4135. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Pasqualucci L, Compagno M, Houldsworth J, Monti S, Grunn A, Nandula SV, Aster JC, Murty VV, Shipp MA and Dalla-Favera R: Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma. J Exp Med. 203:311–317. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Chen R, Alvero AB, Silasi DA, Kelly MG, Fest S, Visintin I, Leiser A, Schwartz PE, Rutherford T and Mor G: Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells. Oncogene. 27:4712–4723. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Al-Katib A, Arnold AA, Aboukameel A, Sosin A, Smith P, Mohamed AN, Beck FW and Mohammad RM: I-kappa-kinase-2 (IKK-2) inhibition potentiates vincristine cytotoxicity in non-Hodgkin's lymphoma. Mol Cancer. 9:2282010. View Article : Google Scholar : PubMed/NCBI | |
|
Jima DD, Zhang J, Jacobs C, Richards KL, Dunphy CH, Choi WW, Au WY, Srivastava G, Czader MB, Rizzieri DA, et al: Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs. Blood. 116:e118–e127. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Montes-Moreno S, Martinez N, Sanchez-Espiridión B, Uriarte Díaz R, Rodriguez ME, Saez A, Montalbán C, Gomez G, Pisano DG, García JF, et al: MiRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy. Blood. 118:1034–1040. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
López AN and Pous LH: MicroRNAs in lymphoma. MicroRNAs in Cancer Translational Research. Cho WCS: (Netherlands, Heidelberg). Springer. 239–267. 2011. View Article : Google Scholar | |
|
Shen J, Liu Z, Todd NW, Zhang H, Liao J, Yu L, Guarnera MA, Li R, Cai L, Zhan M and Jiang F: Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers. BMC Cancer. 11:3742011. View Article : Google Scholar : PubMed/NCBI | |
|
Fassina A, Marino F, Siri M, Zambello R, Ventura L, Fassan M, Simonato F and Cappellesso R: The miR-17–92 microRNA cluster: A novel diagnostic tool in large B-cell malignancies. Lab Invest. 92:1574–1582. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Baraniskin A, Kuhnhenn J, Schlegel U, Chan A, Deckert M, Gold R, Maghnouj A, Zöllner H, Reinacher-Schick A, Schmiegel W, et al: Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system. Blood. 117:3140–3146. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Robertus JL, Harms G, Blokzijl T, Booman M, de Jong D, van Imhoff G, Rosati S, Schuuring E, Kluin P and van den Berg P: Specific expression of miR-17-5p and miR-127 in testicular and central nervous system diffuse large B-cell lymphoma. Mod Pathol. 22:547–555. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Culpin RE, Proctor SJ, Angus B, Crosier S, Anderson JJ and Mainou-Fowler T: A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines. Int J Oncol. 37:367–376. 2010.PubMed/NCBI | |
|
Cao QW, Li HY, Yao XX and Wang JF: Significance of microRNA-146b-5p in diffuse large B-cell lymphoma and its relationship with risk assessment. Zhonghua Xue Ye Xue Za Zhi. 33:1010–1014. 2012.(In Chinese). PubMed/NCBI | |
|
Felli N, Fontana L, Pelosi E, Botta R, Bonci D, Facchiano F, Liuzzi F, Lulli V, Morsilli O, Santoro S, et al: MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci USA. 102:18081–18086. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Le Sage C, Nagel R, Egan DA, Schrier M, Mesman E, Mangiola A, Anile C, Maira G, Mercatelli N, Ciafrè SA, et al: Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J. 26:3699–3708. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Bishton MJ, Hughes S, Richardson F, James E, Bessell E, Sovani V, Ganatra R, Haynes AP, McMillan AK and Fox CP: Delineating outcomes of patients with diffuse large B cell lymphoma using the National Comprehensive Cancer Network-International Prognostic Index and Positron Emission Tomography-defined Remission Status; A population-based analysis. Br J Haematol: Nov. 18:2015.(Epub ahead of print). | |
|
Chen W, Wang H, Chen H, Liu S, Lu H, Kong D, Huang X, Kong Q and Lu Z: Clinical significance and detection of microRNA-21 in serum of patients with diffuse large B-cell lymphoma in Chinese population. Eur J Haematol. 92:407–412. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, et al: Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18:997–1006. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, et al: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA. 105:10513–10518. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N, Benjamin H, Kushnir M, Cholakh H, Melamed N, et al: Serum microRNAs are promising novel biomarkers. PloS One. 3:e31482008. View Article : Google Scholar : PubMed/NCBI | |
|
Ohyashiki K, Umezu T, Yoshizawa S, Ito Y, Ohyashiki M, Kawashima H, Tanaka M, Kuroda M and Ohyashiki JH: Clinical impact of down-regulated plasma miR-92a levels in non-Hodgkin's lymphoma. Plos One. 6:e164082011. View Article : Google Scholar : PubMed/NCBI | |
|
Song G, Gu L, Li J, Tang Z, Liu H, Chen B, Sun X, He B, Pan Y, Wang S and Cho WC: Serum microRNA expression profiling predict response to R-CHOP treatment in diffuse large B cell lymphoma patients. Ann Hematol. 93:1735–1743. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Saito Y, Liang G, Egger G, Friedman JM, Chuang JC, Coetzee GA and Jones PA: Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell. 9:435–443. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Seshadri T, Kuruvilla J, Crump M and Keating A: Salvage therapy for relapsed/refractory diffuse large B cell lymphoma. Biol Blood Marrow Transplant. 14:259–267. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Lee JW, Choi CH, Choi JJ, Park YA, Kim SJ, Hwang SY, Kim WY, Kim TJ, Lee JH, Kim BG and Bae DS: Altered MicroRNA Expression in Cervical Carcinomas. Clin Cancer Res. 14:2535–2542. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Trang P, Medina PP, Wiggins JF, Ruffino L, Kelnar K, Omotola M, Homer R, Brown D, Bader AG, Weidhaas JB and Slack FJ: Regression of murine lung tumors by the let-7 microRNA. Oncogene. 29:1580–1587. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Vester B and Wengel J: LNA (Locked nucleic acid): Highaffinity targeting of complementary RNA and DNA. Biochemistry. 43:13233–13241. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Elmén J, Lindow M, Schütz S, Lawrence M, Petri A, Obad S, Lindholm M, Hedtjärn M, Hansen HF, Berger U, et al: LNA-mediated microRNA silencing in non-human primates. Nature. 452:896–899. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Hammond SM: Soaking up small RNAs. Nat Methods. 4:694–695. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L, D'Urso L, Pagliuca A, Biffoni M, Labbaye C, et al: The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med. 14:1271–1277. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Bai H, Wei J, Deng C, Yang X, Wang C and Xu R: MicroRNA-21 regulates the sensitivity of diffuse large B-cell lymphoma cells to the CHOP chemotherapy regimen. Int J Hematol. 97:223–231. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Gu L, Song G, Chen L, Nie Z, He B, Pan Y, Xu Y, Li R, Gao T, Cho WC and Wang S: Inhibition of miR-21 induces biological and behavioral alterations in diffuse large B-cell lymphoma. Acta Haematol. 130:87–94. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Sud R and Friedberg JW: Salvage therapy for relapsed or refractory diffuse large B-cell lymphoma: Impact of prior rituximab. Haematologica. 93:1776–1780. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Rao E, Jiang C, Ji M, Huang X, Iqbal J, Lenz G, Wright G, Staudt LM, Zhao Y, McKeithan TW, et al: The miRNA-17~92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation. Leukemia. 26:1064–1072. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Shringarpure R, Catley L, Bhole D, Burger R, Podar K, Tai YT, Kessler B, Galardy P, Ploegh H, Tassone P, et al: Gene expression analysis of B-lymphoma cells resistant and sensitive to bortezomib. Br J Haematol. 134:145–156. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Ling H, Fabbri M and Calin GA: MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov. 12:847–865. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Janssen HL, Reesink HW, Lawitz EJ, Zeuzem S, Rodriguez-Torres M, Patel K, van der Meer AJ, Patick AK, Chen A, Zhou Y, et al: Treatment of HCV infection by targeting microRNA. N Engl J Med. 368:1685–1694. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Berglund M, Thunberg U, Amini RM, Book M, Roos G, Erlanson M, Linderoth J, Dictor M, Jerkeman M, Cavallin-Ståhl E, et al: Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis. Mod Pathol. 18:1113–1120. 2005. View Article : Google Scholar : PubMed/NCBI |
